Editor's Correspondence |

Oral Anticoagulant and Dental Procedures

Kai Ming Chow, MD; Cheuk Chun Szeto, MD
Arch Intern Med. 2003;163(20):2532. doi:10.1001/archinte.163.20.2532-a.
Text Size: A A A
Published online


In an otherwise comprehensive review by Dunn and Turpie1 regarding perioperative management of anticoagulated patients, the role of tranexamic acid mouthwash for patients undergoing dental procedures was not addressed. Notwithstanding our concurring with the authors' statement that many dental procedures can be undertaken without alteration of standard oral anticoagulant regimen, additional benefit of simple local hemostatic measures, as exemplified by tranexamic acid mouthwash, should be appraised. The antifibrinolytic action of tranexamic acid lies in its reversible binding to plasminogen. Whereas oral mucosa and saliva are rich in plasminogen activators, local administration of the drug blocks the binding of plasminogen to fibrin and its activation and transformation to plasmin. Tranexamic acid had been proven to attenuate the bleeding risk among patients undergoing oral surgery in 2 well-conducted prospective randomized trials.2,3 Based on the foregoing evidence, it is therefore recommended that for patients undergoing dental procedures, tranexamic acid mouthwash can be applied without interrupting oral anticoagulant therapy,4 as endorsed by the British Committee for Standards in Haematology,5 American Heart Association, and American College of Cardiology.6

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview





Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles